Qyuns Therapeutics Co., Ltd. (stock code: 02509) disclosed a Next Day Disclosure Return dated January 19, 2026, highlighting a repurchase of 53,000 H shares on January 19, 2026. According to the information, the repurchase price ranged between HKD 21.98 and HKD 23.08 per share, resulting in a total aggregate price of HKD 1,181,836.4.

Qyuns Therapeutics reported that its issued shares (excluding treasury shares) stood at 225,286,000 as of January 16, 2026, and decreased to 225,233,000 following the repurchase transaction. Meanwhile, treasury shares increased from 1,785,600 to 1,838,600, keeping the total number of issued shares at 227,071,600.

The purchased 53,000 shares were classified as treasury shares, with no shares canceled. A new share issuance or a sale of treasury shares is subject to a 30-day moratorium period ending on February 18, 2026, in accordance with the applicable rules.